NRx Pharmaceuticals Says FDA Office Of Generic Drugs Found No Bioequivalence Deficiencies At This Time For Preservative-Free Ketamine ANDA, Summer 2026 GDUFA Decision Expected

Benzinga Newsdesk www.benzinga.com Neutral 83.3%

Neg 0% Neu 83.3% Pos 0%

Comments

No comments yet. Be the first!